Which hedge funds own ACRS? ACLARIS THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
33 tracked hedge funds disclosed a position in ACRS (ACLARIS THERAPEUTICS INC) in their Q2 2026 13F filings, worth $366.9m in total. The largest holder by portfolio weight is BML Capital Management, LLC at 36.2% of its book. 10 opened a new position this quarter: Jones Hill Capital LP, Silverarc Capital Management, LLC, Tetragon Partners GP Ltd, Atom Investors LP. 6 exited: EntryPoint Capital, LLC, ADAR1 Capital Management, LLC, Marshall Wace, LLP.
33
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
10
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
6
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$26.1m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$4.2m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$367m
Combined value
Sum of the holders' reported positions in the security.
2.7%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.